In 55–74% of IFP cases the presence of oncogenic PDGFRA mutations, affecting specifically exons 12, 14 and 18, is observed, as in other stromal tumors (GIST), suggesting that these lesions may arise due to the activation of PDGFRA [27]. This evidence concerns the gene PDGFRA and gastrointestinal stromal tumor.